Overall, these findings highlight the promising role of LNP-mediated delivery of uniSTING-mRNA in overcoming therapeutic barriers associated with STING agonist therapy, particularly in cancers with downregulated or absent STING expression [169]. Here, STING1 is linked to cancer.